|
麗珠醫藥集團股份有限公司- H股, 01513.HK - 綜合損益表 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
2013-12 |
2012-12 |
營業額 |
12,629,579 |
12,063,863 |
10,520,410 |
9,384,696 |
8,860,656 |
8,530,969 |
7,651,775 |
6,620,517 |
5,544,234 |
4,618,680 |
3,943,525 |
經營溢利 |
2,350,556 |
2,266,990 |
2,500,449 |
1,729,853 |
1,274,496 |
5,657,808 |
881,317 |
692,799 |
584,509 |
590,557 |
518,753 |
非經營/ 特殊項目 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
聯營公司 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
除稅前經營溢利 |
2,330,551 |
2,245,689 |
2,489,436 |
1,727,542 |
1,416,674 |
5,724,923 |
1,005,061 |
807,921 |
652,025 |
628,940 |
560,313 |
稅項 |
375,010 |
293,588 |
358,109 |
265,965 |
234,960 |
1,237,220 |
175,146 |
148,358 |
98,403 |
104,954 |
85,090 |
少數股東權益 |
46,149 |
176,418 |
416,416 |
158,702 |
99,540 |
59,018 |
45,562 |
36,922 |
37,644 |
36,484 |
33,552 |
股東應占溢利 |
1,909,392 |
1,775,683 |
1,714,910 |
1,302,875 |
1,082,175 |
4,428,685 |
784,354 |
622,641 |
515,978 |
487,502 |
441,672 |
貨幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
人民幣 |
單位 |
主要項目 |
折舊 |
652,324 |
445,271 |
131,211 |
138,682 |
117,492 |
55,049 |
61,509 |
43,235 |
257,538 |
179,974 |
151,987 |
利息 |
97,546 |
83,997 |
25,313 |
7,255 |
16,773 |
3,050 |
26,967 |
31,329 |
26,855 |
9,063 |
30,982 |
利息撥作發展資本 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
32,628 |
41,723 |
13,800 |
處置/重估固定資產 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
稅率(%) |
16.09 |
13.07 |
14.39 |
15.4 |
16.59 |
21.61 |
17.43 |
18.36 |
15.09 |
16.69 |
15.19 |
營業額增長(%) |
4.69 |
14.67 |
12.1 |
5.91 |
3.86 |
11.49 |
15.58 |
19.41 |
20.04 |
17.12 |
24.68 |
股東應占溢利增長(%) |
7.53 |
3.54 |
31.63 |
20.39 |
-75.56 |
464.63 |
25.97 |
20.67 |
5.84 |
10.38 |
22.9 |
核數師意見 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
0 |
說明:1代表無保留意見;2代表保留意見;3代表修改意見
|
|